Analyst Price Target is $41.33
▲ +152.65% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Arcus Biosciences in the last 3 months. The average price target is $41.33, with a high forecast of $51.00 and a low forecast of $33.00. The average price target represents a 152.65% upside from the last price of $16.36.
Current Consensus is
The current consensus among 9 polled investment analysts is to buy stock in Arcus Biosciences. This Buy consensus rating has held steady for over two years.